8 Companies Hiring Now in New York
Looking for a biopharma job in New York? Check out the BioSpace list of eight companies hiring life sciences professionals like you.
Looking for a biopharma job in New York? Check out the BioSpace list of eight companies hiring life sciences professionals like you.
El humo del tabaco es conocido por sus efectos nocivos en la salud humana, pero pocas veces se habla de su impacto en otro grupo de seres vivos esenciales para la vida en la Tierra: las plantas. Diversos estudios científicos han demostrado que la exposición al humo del tabaco, incluso …
Nearly one-third of biotech and pharma professionals are thinking about leaving the U.S. to find biopharma jobs, according to a BioSpace LinkedIn poll. Career coaches discuss why people are considering relocating and what they should do before heading for the exit.
Almost 1/3 Eyeing Job Options Outside US, BioSpace Finds Read More »
Generic versions of biologic drugs could hit the market without human trials and allow the market forces to bring down costs, HHS leaders said while announcing new draft guidance.
FDA Proposes Lower Bar for Biosimilar Approvals in Bid To Lower Drug Prices Read More »
Descubre cómo la analítica de video con IA está redefiniendo la seguridad urbana — ejemplos reales, productos destacados y prácticas éticas para una implementación efectiva. Seamos honestos: las ciudades actuales son más complejas que n …
The healthcare giant beat Wall Street expectations in the third quarter, but reported a net loss after recording a $5.7 billion charge linked primarily to decelerating clinic growth at Oak Street Health.
CVS hikes 2025 guidance despite goodwill impairment charge on healthcare delivery Read More »
National Medicare coverage paves the way for a larger patient population to access the blood pressure treatment, which gained FDA approval in 2023.
CMS grants NCD for renal denervation, benefiting Medtronic, Recor Read More »
Late-breaking Phase III data show ianalumab, Novartis’ dual-targeted antibody, reduced disease activity and patient burden in Sjögren’s disease, the pharma reported at the American College of Rheumatology Convergence congress on Wednesday.
Novartis Presents New Data From Potential First Targeted Sjögren’s Treatment Read More »
More than 60% of respondents said insurance companies are most at fault for medical debt, compared with just 9% who blamed hospitals, according to a survey by nonprofit Undue Medical Debt.
The purchase is expected to complement Thermo’s clinical research services, as companies are conducting more clinical trials.
Thermo Fisher to acquire clinical trial data firm Clario for $8.9B Read More »